Post-earnings recap
Reported
Thu, Feb 2, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.46%, likely due to a lack of revenue details and forward guidance, which may have left investors uncertain about future performance. The cautious tone from management suggests they are aware of challenges ahead but remain focused on their strategic goals.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.09 | N/A | +14.27% |
| Revenue | N/A | N/A | N/A |
Management remains focused on advancing their pipeline and addressing market dynamics. They emphasized the importance of their product portfolio.
Management highlighted strong performance in key therapeutic areas.
They expressed commitment to ongoing innovation despite market challenges.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—